RT Journal Article
SR Electronic
T1 Arterial spin labeling as a promising alternative to FDG-PET for clinical diagnosis of patients with disorders of consciousness
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.07.24311648
DO 10.1101/2024.08.07.24311648
A1 Han, Junrong
A1 Duncan, Niall W.
A1 Huang, Likai
A1 Lee, Chia
A1 Yang, Che-Ming
A1 Wu, Yen-Chien
A1 Chen, David Yen-Ting
A1 Lane, Timothy J.
YR 2024
UL http://medrxiv.org/content/early/2024/08/08/2024.08.07.24311648.abstract
AB Objective To evaluate the potential of arterial spin labeling (ASL) as an alternative to FDG-PET in the diagnosis of disorders of consciousness (DOC), we conducted a comparative study of the two modalities.Methods A total of 36 DOC patients (11 female; mean age = 49.67 ± 14.54 years) and 17 healthy control (HC) participants (9 female; mean age = 31.9 ± 9.6 years) underwent both FDG-PET scans that measure metabolism via glucose uptake and ASL scans that measure cerebral blood flow (CBF). CBF and metabolism in DOC and HC were compared, globally and for seven functional networks. Comparability of the two modalities was estimated using Spearman partial correlation for both global and network levels. Furthermore, a support vector machine (SVM) algorithm was used to train two classifiers to distinguish DOC patients from HC with normalized CBF or metabolism values from the seven networks. Performance of these classifiers was first evaluated through leave-one-subject-out (LOSO) cross-validation within their respective modalities. Subsequently, cross-modal validation was conducted: testing the ASL-trained classifier with PET data (ASL-to-PET validation) and vice versa (PET-to-ASL validation). Performance of each classifier was assessed using receiver operating characteristic (ROC) analysis, with area under the curve (AUC) as the metric.Results Both modalities showed agreement in decreased CBF and metabolism in DOC patients compared to HC, at both global and network levels. The global brain and most networks showed significant positive partial correlation between CBF and metabolism. SVM classifiers, utilizing activity from seven networks as features, performed well in the both LOSO cross-validation (ASL-trained classifier: accuracy = 83.02%, AUC = 0.95; PET-trained classifier: accuracy = 98.12%, AUC = 0.98) and cross-modal validation (ASL-to-PET validation: accuracy = 84.90%, AUC =0.92; PET-to-ASL validation: accuracy = 73.58%, AUC = 0.93).Conclusion Our results demonstrate that ASL provides information comparable to FDG-PET for DOC patients; moreover, classifiers trained on ASL data perform comparably well to those trained on FDG-PET data. Therefore, ASL could be a valuable alternative to FDG-PET in the clinical diagnosis of DOC, especially in light of its advantages: ease of acquisition, avoidance of radiation exposure, brevity of scanning time, and lower-cost.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by grants to TJL from the Taiwan National Science and Technology Council (105-2632-H-038-001-MY3, 106-2410-H-038-003-MY3, 111-2410-H-038-012), as well as by donations to the Brain and Consciousness Research Centre (Taiwan Ministry of Health and Welfare registration number: T063). NWD acknowledges support from the Taiwan National Science and Technology Council (110-2628-H-038-001-MY4).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committess/IRB of Taipei Medical University gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors ASLarterial spin labelingAUCarea under the curveCBFcerebral blood flowCRS-RComa Recovery Scale-RevisedCSFcerebrospinal fluidDOCdisorders of consciousnessDANdorsal attention networkDMNdefault mode networkFDG-PET[18F]-fluorodeoxyglucose-positron emission tomographyFPNfrontoparietal networkLNlimbic networkMCSminimally consciousness statepCASLPseudo-Continuous Arterial Spin LabelingROCreceiver operating characteristicROIsregions of interestSMNsomatomotor networkSVMsupport vector machineUWSunresponsive wakefulness syndromeVANventral attention networkVNvisual network